Yvonne McGrath

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Adi Osovsky, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Yvonne McGrath:

Company Role Class Num Shares Value Price $ Report Date Ownership
iTeos Therapeutics, Inc. Chief Scientific Officer Common Stock 0 $0 $10.29 29 Aug 2025 Direct
iTeos Therapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 0 29 Aug 2025 Direct

Insider Reports Filed by Yvonne McGrath

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ITOS iTeos Therapeutics, Inc. 29 Aug 2025 4 $0 4 Chief Scientific Officer 29 Aug 2025, 16:30
ITOS iTeos Therapeutics, Inc. 07 Mar 2025 2 $0 4 Chief Scientific Officer 11 Mar 2025, 20:00
ITOS iTeos Therapeutics, Inc. 07 Mar 2024 1 $0 4 Chief Scientific Officer 08 Mar 2024, 19:58
ITOS iTeos Therapeutics, Inc. 05 Dec 2023 1 $0 4 Chief Scientific Officer 07 Dec 2023, 20:22
ITOS iTeos Therapeutics, Inc. 09 Mar 2023 1 $0 4 Chief Scientific Officer 10 Mar 2023, 18:54
ITOS iTeos Therapeutics, Inc. 11 Mar 2022 1 $0 4 Chief Scientific Officer 14 Mar 2022, 20:02
ITOS iTeos Therapeutics, Inc. 01 Mar 2022 3 -$325,170 4 Chief Scientific Officer 02 Mar 2022, 18:59
ITOS iTeos Therapeutics, Inc. 08 Jun 2021 3 -$125,009 4 VP, Research and Development 10 Jun 2021, 17:35
ITOS iTeos Therapeutics, Inc. 01 Jun 2021 6 -$126,371 4 VP, Research and Development 03 Jun 2021, 16:17
ITOS iTeos Therapeutics, Inc. 24 May 2021 3 -$140,265 4/A VP, Research and Development 03 Jun 2021, 16:19
ITOS iTeos Therapeutics, Inc. 17 May 2021 5 -$162,192 4 VP, Research and Development 19 May 2021, 16:14